Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
New MASAC Recommendations Available on NHF Web site
 

The National Hemophilia Foundation's (NHF) Medical and Scientific Advisory Council (MASAC) issued the following recommendations on April 22, 2006 and the NHF Board of Directors subsequently approved them on June 3, 2006. These documents are available on the NHF Web site.

MASAC Document #167: MASAC Recommendation Regarding the Use of Bypassing Agents in Patients with Hemophilia A or B and Inhibitors

MASAC Document # 168: MASAC Recommendation Regarding Access to Care
For Patients with Bleeding Disorders

MASAC Document #169 (Replaces #106): MASAC Recommendation Regarding the Use of Recombinant Clotting Factor Products with Respect to Pathogen Transmission

MASAC Document #170 (Replaces #117): MASAC Recommendation Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding)

To request a copy of any or all of the new recommendations, contact HANDI: 800.424.2634 (option two) or handi@hemophilia.org.

 

 

This section of our Web site is sponsored by: